Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pancreatic transduction by helper-dependent adenoviral vectors via intraductal delivery

  • Morró Larrubia, Meritxell|||0000-0003-1725-9599
  • Teichenne, Joan|||0000-0002-3455-5923
  • Jimenez, Veronica|||0000-0001-9145-9877
  • Kratzer, Ramona
  • Marletta, Serena
  • Maggioni, Luca
  • Mallol, Cristina|||0000-0002-2920-9612
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Kochanek, Stefan
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • Ayuso, Eduard|||0000-0003-0811-2229
Pancreatic gene transfer could be useful to treat several diseases, such as diabetes mellitus, cystic fibrosis, chronic pancreatitis, or pancreatic cancer. Helper-dependent adenoviral vectors (HDAds) are promising tools for gene therapy because of their large cloning capacity, high levels of transgene expression, and long-term persistence in immunocompetent animals. Nevertheless, the ability of HDAds to transduce the pancreas in vivo has not been investigated yet. Here, we have generated HDAds carrying pancreas-specific expression cassettes, that is, driven either by the elastase or insulin promoter, using a novel and convenient plasmid family and homologous recombination in bacteria. These HDAds were delivered to the pancreas of immunocompetent mice via intrapancreatic duct injection. HDAds, encoding a CMV-GFP reporter cassette, were able to transduce acinar and islet cells, but transgene expression was lost 15 days postinjection in correlation with severe lymphocytic infiltration. When HDAds encoding GFP under the control of the specific elastase promoter were used, expression was detected in acinar cells, but similarly, the expression almost disappeared 30 days postinjection and lymphocytic infiltration was also observed. In contrast, long-term transgene expression (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy

  • Haurigot Mendonça, Virginia|||0000-0002-9772-2565
  • Villacampa, Pilar|||0000-0002-2860-7475
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Ramos González, David
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Neovascularization associated with diabetic retinopathy (DR) and other ocular disorders is a leading cause of visual impairment and adult-onset blindness. Currently available treatments are merely palliative and offer temporary solutions. Here, we tested the efficacy of antiangiogenic gene transfer in an animal model that mimics the chronic progression of human DR. Adeno-associated viral (AAV) vectors of serotype 2 coding for antiangiogenic Pigment Epithelium Derived Factor (PEDF) were injected in the vitreous of a 1.5 month-old transgenic model of retinopathy that develops progressive neovascularization. A single intravitreal injection led to long-term production of PEDF and to a striking inhibition of intravitreal neovascularization, normalization of retinal capillary density, and prevention of retinal detachment. This was parallel to a reduction in the intraocular levels of Vascular Endothelial Growth Factor (VEGF). Normalization of VEGF was consistent with a downregulation of downstream effectors of angiogenesis, such as the activity of Matrix Metalloproteinases (MMP) 2 and 9 and the content of Connective Tissue Growth Factor (CTGF). These results demonstrate long-term efficacy of AAV-mediated PEDF overexpression in counteracting retinal neovascularization in a relevant animal model, and provides evidence towards the use of this strategy to treat angiogenesis in DR and other chronic proliferative retinal disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In Vivo Adeno-Associated Viral Vector-Mediated Genetic Engineering of White and Brown Adipose Tissue in Adult Mice

  • Jimenez, Veronica|||0000-0001-9145-9877
  • Muñoz-Martínez, S|||0000-0003-0663-0575
  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Mallol, Cristina|||0000-0002-2920-9612
  • Elias Puigdomenech, Ivet|||0000-0002-1304-9597
  • Jambrina Pallarés, Claudia
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Ferre, Tura|||0000-0001-9713-0829
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Adipose tissue is pivotal in the regulation of energy homeostasis through the balance of energy storage and expenditure and as an endocrine organ. An inadequate mass and/or alterations in the metabolic and endocrine functions of adipose tissue underlie the development of obesity, insulin resistance, and type 2 diabetes. To fully understand the metabolic and molecular mechanism(s) involved in adipose dysfunction, in vivo genetic modification of adipocytes holds great potential. Here, we demonstrate that adeno-associated viral (AAV) vectors, especially serotypes 8 and 9, mediated efficient transduction of white (WAT) and brown adipose tissue (BAT) in adult lean and obese diabetic mice. The use of short versions of the adipocyte protein 2 or uncoupling protein-1 promoters or micro-RNA target sequences enabled highly specific, long-term AAV-mediated transgene expression in white or brown adipocytes. As proof of concept, delivery of AAV vectors encoding for hexokinase or vascular endothelial growth factor to WAT or BAT resulted in increased glucose uptake or increased vessel density in targeted depots. This method of gene transfer also enabled the secretion of stable high levels of the alkaline phosphatase marker protein into the bloodstream by transduced WAT. Therefore, AAV-mediated genetic engineering of adipose tissue represents a useful tool for the study of adipose pathophysiology and, likely, for the future development of new therapeutic strategies for obesity and diabetes.